Biodesix Inc
NASDAQ:BDSX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
UBA Investments Ltd
HKEX:768
|
HK |
|
Vestas Wind Systems A/S
OTC:VWSYF
|
DK |
Biodesix Inc
Non-Reccuring Items
Biodesix Inc
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biodesix Inc
NASDAQ:BDSX
|
Non-Reccuring Items
-$107k
|
CAGR 3-Years
75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Non-Reccuring Items
-$95m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Non-Reccuring Items
-$5.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Non-Reccuring Items
-$1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Non-Reccuring Items
-$131.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
23%
|
CAGR 10-Years
-1%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Non-Reccuring Items
-$4.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biodesix Inc
Glance View
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The company is headquartered in Boulder, Colorado and currently employs 218 full-time employees. The company went IPO on 2020-10-28. The firm uses its artificial intelligence (AI) platform, Diagnostic Cortex, to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus on lung disease. In addition to its diagnostic tests, it provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development and commercialization of companion diagnostics. The firm offers blood-based lung cancer tests across the lung cancer continuum of care, including Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. The firm also offers three SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralization Antibody Test.
See Also
What is Biodesix Inc's Non-Reccuring Items?
Non-Reccuring Items
-107k
USD
Based on the financial report for Dec 31, 2025, Biodesix Inc's Non-Reccuring Items amounts to -107k USD.
What is Biodesix Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 3Y
75%
Over the last year, the Non-Reccuring Items growth was 78%. The average annual Non-Reccuring Items growth rates for Biodesix Inc have been 75% over the past three years .
